Partner With Us NRI

Kerala Ayurveda Ltd

Company details

6M Return 36.09%
1Y Return 44.34%
Mkt Cap.(Cr) 110.47
Volume 7,946
Div Yield 0.00%
OI Chg %
Volume 7,946

Open Free Demat Account Online with ICICIDIRECT



Operating Profit

Profit after Tax


Reserves and Surplus



Operating Profit

Profit after Tax






Equity Capital: 6.11 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 17,871.26 -28,732.63
LAST 3M 35,065.84 -30,146.79
LAST 6M 57,360.50 38,576.46
LAST 12M 186,944.70 -113,961.48


Stock PE (TTM)


Promoter Holding


Book Value







  • Kerala Ayurvedic Pharmacy has emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company has drawn on the rich experience of its parent companies - Kerala Pharmacy and Pensen Drugs and Pharmaceuticals - which were merged in 1992. The company came out with a public issue in Feb.`95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines. It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye. The company is in the midst of enhancing the installed capacity at its Athani plant to produce traditional ayurvedic medicines. Moreover, the company proposes to organise and relocate its twelve clinics to cover all the principal districts in Kerala and augment facilities at its clinics in Bombay, Madras, Bangalore and Mangalore. In addition, it is increasing the bed strength of its hospital in Alwaye. Kerala Ayurvedic has won the approval of the Karnataka Toursim Development Department to open a health resort at Bangalore catering exclusively to the high income segments, tourists and NRIs. The company has a well-entrenched presence in several states due to its 75 franchisees and 400 stockists. During the year 1999-2000, the company exported medicines worth Rs. 56.43 lacs to USA, UK, Italy, Malaysia, Holland and Japan. Four new products have been developed during the year and intial reports are quite encouraging. Clinical studies conducted for patent products have established their efficiency and has also been affirmed by ayurvedic doctors for prescription. In Bangalore a new Ayurvedic Health resort has started its operation in March 2001 and the trial run had a good response.The company is planning to develop new methods for rare medicinal plants using biofertilizers.

Registered Address

VII/415 Nedumbassery, Athani P O Aluva, Ernakulam, Kerala, 683585

Tel : 91-484-2476301/2/3/4
Email : info:keralaayurveda.biz
Website : http://www.keralaayurveda.biz


Integrated Registry Mgt Servic

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 530163
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE817B01025

ICICIdirect Kerala Ayurveda Ltd FAQ

You can buy Kerala Ayurveda Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Kerala Ayurveda Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 03, 2023 04:01 PM the closing price of Kerala Ayurveda Ltd was ₹ 104.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 03, 2023 04:01 PM, the market cap of Kerala Ayurveda Ltd stood at ₹ 110.47.
The latest PE ratio of Kerala Ayurveda Ltd as of Feb 03, 2023 04:01 PM is 39.13
The latest PB ratio of Kerala Ayurveda Ltd as of Feb 03, 2023 04:01 PM is 0.06
The 52-week high of Kerala Ayurveda Ltd is ₹ 119.25 while the 52-week low is ₹ 62.80

Download Our App

market app
market app